Close

Depomed (DEPO) Debuts New CAMBIA Formulation; Includes Sucralose Sweetener

Go back to Depomed (DEPO) Debuts New CAMBIA Formulation; Includes Sucralose Sweetener

Depomed Announces New CAMBIA® Formulation

November 4, 2016 8:00 AM EDT

NEWARK, Calif., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Depomed Inc. (NASDAQ: DEPO) today announced the introduction of a new formulation of CAMBIA® (diclofenac potassium) for oral solution, that contains the sweetener sucralose, replacing the sweeteners saccharin sodium and aspartame. The new formulation, which was approved by the U.S. Food and Drug Administration, addresses some patient sensitivities towards certain sweeteners and is not as a result of any product safety concerns nor does it alter the efficacy profile of the product. CAMBIA® with sucralose will be available following the dispensing of current inventories containing... More